πŸ’‰

Other Drugs

πŸ’Š Drugs β€’ 3,200 recalls

Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.

May 12, 2014 Other Drugs Nationwide View Details β†’

Marketed Without An Approved NDA/ANDA: Product is being recalled due to excessive levels of lovastatin. Lovastatin is an FDA approved drug making this dietary supplement an unapproved new drug.

Apr 29, 2014 Other Drugs Nationwide View Details β†’

Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.

Jul 19, 2013 Other Drugs Nationwide View Details β†’